Recipient organisationNIHR Leicester Biomedical Research Centre
NIHR supportRecorded as supported by this research centre
PeriodJan 2025 — Ongoing
In plain English
AI plain-English summary
Around one in three people with type 1 diabetes lose the ability to feel the warning signs of dangerously low blood sugar—sweating, shaking, palpitations—that tell them to eat or drink sugar before they collapse. This condition, called impaired awareness of hypoglycaemia (IAH), dramatically raises the risk of severe episodes that require help from others and can lead to unconsciousness or death. Current treatments—either an automated insulin pump system (hybrid closed loop) or an educational course on insulin management—have each shown partial success in reducing hypoglycaemia, but neither has been proven to restore awareness reliably. The CLEAR study will directly compare these two approaches by randomly assigning adults aged 18–75 with IAH across eight specialist centres in the USA and Australia, then measuring their awareness at one and two years. If one treatment proves clearly better at restoring the body’s natural warning system, it could change clinical guidelines and give patients a practical, evidence-based path to safer daily life—reducing the constant fear and dependence on others that severe hypoglycaemia brings.
View original technical description
Hypoglycaemia (low blood glucose) is an inevitable complication of the insulin treatment of diabetes, occurring whenever the insulin dose taken is more than the body needs. When the blood glucose drops low, the body ordinarily gives out warning signs, with symptoms such as sweating, shaking and palpitations. These symptoms alert the person to eat or drink sugar and stop the fall. If hypoglycaemia remains untreated, blood glucose can drop very low, leading to loss of consciousness or very rarely, death. Around one third of people with type 1 diabetes (T1D) lose their ability to recognise symptoms of hypoglycaemia in a timely fashion. This is known as impaired awareness of hypoglycaemia (IAH). IAH increases the risk of severe hypoglycaemia, with impaired brain function, where the person needs help from others to recover. We still need to work out what treatments are most effective. Technologies such as Hybrid Closed Loop systems (a continuous glucose monitor connected to an insulin pump which adjusts the insulin according to the glucose) have, in shorter studies, reduced hypoglycaemic episodes but have not been shown to restore awareness. Educational courses, which aim to address knowledge of insulin action and behaviours related to low blood glucose have previously been shown to restore awareness in some but not in all people with T1D. The CLEAR study (Closed Loop and Education for Hypoglycaemia Awareness Restoration) will study and compare the effectiveness of new technologies and educational courses at restoring hypoglycaemia awareness, by randomising participants to these treatments (their treatment is chosen by chance). Their awareness of hypoglycaemia will be measured at the start, after 1 year and after 2 years. Participants with T1D, aged 18-75, with impaired awareness of hypoglycaemia, will be recruited across 8 specialist diabetes centres in the USA, Aus
Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.
Is something wrong? Let us know